KRAS and cancer: Despite their different origin, whole-genome sequencing studies have shown that their transition from precursor lesions to malignant neoplasms is caused by a first generation of point mutations in the KRAS gene, followed by mutations in tumour suppressor genes such as CDKN2A, TP53 or SMAD4 [6].